Medicinal cannabis data group CB2 Insights Inc (CSE:CBII) (OTCQB:CBIIF) has announced it is expanding its market presence in the UK, boosting CBII stock by 5%.
The company, which specializes in research and data collection to offer a suite of technology solutions in the medicinal cannabis industry, has said it will license its technology to MyAccess Clinics (MAC) to manage their patient data. MAC operates several clinics in the UK for patients seeking medicinal cannabis care due to conventional treatments being ineffective. MAC will use CB2 Insights’ Electronic Data Capture Technology (EDCT) to capture comprehensive data sets ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.